A 28-year-old Indian male presents with a 3-year history of progressive neurological decline, including ataxia, dysarthria, and cognitive decline. His parents are consanguineous. Laboratory investigations show elevated alpha-fetoprotein (AFP) and carcinoembryonic antigen (CEA). Genetic testing identifies mutations in the ATM gene. Which of the following mechanisms best explains the neurological degeneration in this patient?

Explanation

## Clinical Diagnosis: Ataxia-Telangiectasia (A-T) **Key Point:** Ataxia-telangiectasia is an autosomal recessive disorder caused by mutations in the ATM (Ataxia Telangiectasia Mutated) gene, which encodes a serine/threonine kinase critical for double-strand break (DSB) detection and repair. ### Role of ATM Protein in DSB Response The ATM protein is a master regulator of the DNA damage response: 1. **Sensor function:** Detects DSBs via direct interaction with MRN complex (MRE11-RAD50-NBS1) 2. **Transducer function:** Phosphorylates downstream targets including: - p53 (tumor suppressor activation) - CHK2 (checkpoint kinase) - BRCA1 (homologous recombination repair) 3. **Effector function:** Coordinates cell cycle arrest, apoptosis, or DNA repair **High-Yield:** Without functional ATM, cells cannot properly sense or repair DSBs, leading to: - Chromosomal instability - Accumulation of mutations - Selective neuronal death (neurons are post-mitotic and cannot dilute damaged DNA) - Increased cancer risk ### Why Neurological Degeneration Occurs ```mermaid flowchart TD A[ATM mutation]:::outcome --> B[Impaired DSB sensing]:::outcome B --> C[Unrepaired DNA damage accumulates]:::outcome C --> D{Cell type?}:::decision D -->|Dividing cells| E[Checkpoint arrest or apoptosis]:::action D -->|Post-mitotic neurons| F[Damage accumulation → cell death]:::urgent F --> G[Progressive neuronal loss]:::outcome G --> H[Ataxia, cognitive decline]:::outcome ``` **Clinical Pearl:** Neurons are particularly vulnerable because they: - Cannot undergo mitosis to dilute damaged DNA - Have high metabolic rates and generate reactive oxygen species (ROS) - Accumulate DSBs over decades, eventually triggering apoptosis ### Clinical Features of A-T | Feature | Mechanism | |---------|----------| | Progressive ataxia (cerebellar) | Purkinje cell loss due to DSB accumulation | | Oculomotor apraxia (telangiectasia) | Vascular endothelial damage | | Immunodeficiency (T-cell lymphopenia) | Impaired V(D)J recombination in developing lymphocytes | | Elevated AFP and CEA | Increased cancer risk (lymphomas, leukemias) | | Radiosensitivity | Inability to repair radiation-induced DSBs | | Increased cancer risk (100-fold) | Chromosomal instability and p53 dysfunction | **Mnemonic:** **ATM = Always Terrible at Mending** — double-strand breaks. ### Why Not the Other Options? - **NER defect** would cause photosensitivity (like XP), not ataxia - **MMR defect** would cause Lynch syndrome, not neurological degeneration - **Telomerase loss** would cause premature aging (dyskeratosis congenita), not this presentation [cite:Robbins 10e Ch 7; Alberts Molecular Biology of the Cell 6e Ch 5]